Company believes the cash on hand at December 31, 2018 will be sufficient to meet its obligations as they become due in the ordinary
course of business for at least 12 months following the date these financial statements are issued. The Company has sustained
operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company
expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing
operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of
clinical adoption within the installed base of robotic magnetic systems as well as by new placements of capital systems. The Company
also may consider raising cash through capital transactions, which could include either debt or equity financing.
we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily
generated from the proceeds of our past and future public offerings, private sales of our equity securities and working capital
and equipment financing loans. In the future, we may finance cash needs through the sale of other equity securities or non-core
assets, strategic collaboration agreements, debt financings or through distribution rights. We cannot assure you that such additional
financing will be available on a timely basis on terms acceptable to us or at all, that we will be able to engage in equity financings
because our common stock is no longer listed on a national securities exchange, or that such financing will not be dilutive to
our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of
new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to
commercialize ourselves or to reduce the sales, marketing, customer support or other resources devoted to our products, any of
which could have a material adverse effect on our business, financial condition and results of operations. In addition, we could
be required to cease operations.
do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as
entities often referred to as structured finance or special purpose entities, which would have been established for the purpose
of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage
in trading activities involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity,
market or credit risk that could have arisen if we had engaged in these relationships.